netFormulary
 Report : A-Z HCD items in Formulary 23/12/2024 03:22:56
[Back]
 
Section Status HCD Name
10.01.03 Restricted Use Cancer Drugs Fund Abatacept Orencia®
01.05.03 Restricted Use Cancer Drugs Fund Adalimumab Humira®
10.01.03 Restricted Use Cancer Drugs Fund Adalimumab 
11.99.99.99 Formulary Cancer Drugs Fund Adalimumab Humira®
13.05.03 Formulary Cancer Drugs Fund Adalimumab 
08.01.05 Formulary Cancer Drugs Fund Afatinib Giotrif®
11.08.02 Restricted Use Cancer Drugs Fund Aflibercept Eylea®
08.02.03 Formulary Cancer Drugs Fund Alemtuzumab Lemtrada®
06.06.02 Formulary Cancer Drugs Fund Alendronic acid Binosto®
13.10.02 Formulary Cancer Drugs Fund Amorolfine 5% 
10.01.03 Restricted Use Cancer Drugs Fund Anakinra Kineret®
13.05.03 Formulary Cancer Drugs Fund Apremilast  
08.02.03 Formulary Cancer Drugs Fund Atezolizumab Tecentriq®
08.02.03 Formulary Cancer Drugs Fund Avelumab Bavencio®
01.05.01 Formulary Cancer Drugs Fund Balsalazide Sodium Colazide ®
10.01.03 Formulary Cancer Drugs Fund Baricitinib Olumiant®
08.02.03 Formulary Cancer Drugs Fund Blinatumomab Blincyto®
08.01.05 Formulary Cancer Drugs Fund Bosutinib Bosulif®
08.01.05 Restricted Use Cancer Drugs Fund Cabazitaxel Jevtana®
08.01.05 Formulary Cancer Drugs Fund Cabozantinib Cabometyx®
10.03.02 Formulary Cancer Drugs Fund Capsaicin cream 0.025% 
08.01.05 Restricted Use Cancer Drugs Fund Carfilzomib Kyprolis®
08.01.05 Formulary Cancer Drugs Fund Ceritinib Zykadia®
10.01.03 Restricted Use Cancer Drugs Fund Certolizumab Pegol Cimzia®
08.02.04 Formulary Cancer Drugs Fund Cladribine Mavenclad®
10.03.01 Formulary Cancer Drugs Fund Collagenase clostridium histolyticum Xiapex®
08.01.05 Formulary Cancer Drugs Fund Crizotinib Xalkori®
08.01.05 Formulary Cancer Drugs Fund Dasatinib Sprycel®
A5.05.03 Formulary Cancer Drugs Fund Debrisoft® 
08.03.04.02 Formulary Cancer Drugs Fund Degarelix 
11.04.01 Restricted Use Cancer Drugs Fund Dexamethasone 700mcg  Ozurdex®
13.08.01 Formulary Cancer Drugs Fund Diclofenac 3% gel Solaraze®
08.03.01 Formulary Cancer Drugs Fund Diethylstilbestrol 
13.05.03 Formulary Cancer Drugs Fund Dimethyl fumarate Skilarence®
08.01.05 Restricted Use Cancer Drugs Fund Docetaxel Taxotere®
09.08.01 Formulary Cancer Drugs Fund Eliglustat Cerdelga®
08.01.05 Formulary Cancer Drugs Fund Eribulin Halaven®
08.01.05 Formulary Cancer Drugs Fund Erlotinib Tarceva®
10.01.03 Restricted Use Cancer Drugs Fund Etanercept Enbrel®
13.05.03 Formulary Cancer Drugs Fund Etanercept 
08.01.05 Formulary Cancer Drugs Fund Everolimus Afinitor®
02.06.02 Formulary Cancer Drugs Fund Felodipine 
13.04 Formulary Cancer Drugs Fund Flucinolone Acetonide 0.025% Synalar® Gel
13.04 Formulary Cancer Drugs Fund Fludroxycortide tape Previously known as Haelan®
11.03.01 Formulary Cancer Drugs Fund Fusidic acid 
05.03.03.02 Formulary Cancer Drugs Fund Glecaprevir-pibrentasvir Maviret®
13.12 Formulary Cancer Drugs Fund Glycopyrronium 
01.05 Restricted Use Cancer Drugs Fund Golimumab Simponi®
10.01.03 Restricted Use Cancer Drugs Fund Golimumab Simponi®
08.01.05 Formulary Cancer Drugs Fund Ibrutinib Imbruvica®
08.01.05 Formulary Cancer Drugs Fund Idelalisib Zydelig®
08.01.05 Formulary Cancer Drugs Fund Imatinib Glivec®
13.08.01 Formulary Cancer Drugs Fund Imiquimod 3.75% Zyclara®
01.05.03 Restricted Use Cancer Drugs Fund Infliximab Remicade®
10.01.03 Restricted Use Cancer Drugs Fund Infliximab 
13.10.02 Formulary Cancer Drugs Fund Ketoconazole 2% cream 
08.01.05 Formulary Cancer Drugs Fund Lenvatinib Kisplyx®
11.03.01 Formulary Cancer Drugs Fund Levofloxacin Oftaquix®
01.05 Formulary Cancer Drugs Fund Mesalazine 
06.01.02.02 Formulary Cancer Drugs Fund Metformin 
08.01.05 Formulary Cancer Drugs Fund Midostaurin Rydapt®
08.02.01 Formulary Cancer Drugs Fund Mycophenolate Mofetil  
10.02.01 Formulary Cancer Drugs Fund Mycophenolate mofetil 
03.11 Formulary Cancer Drugs Fund Nintedanib Vargatef®
08.02.03 Formulary Cancer Drugs Fund Nivolumab Opdivo®
08.02.03 Formulary Cancer Drugs Fund Obinutuzumab Gazyvaro®
08.02.03 Formulary Cancer Drugs Fund Ofatumumab Arzerra®
08.01.05 Formulary Cancer Drugs Fund Olaparib Lynparza®
11.04.02 Formulary Cancer Drugs Fund Olopatadine Opatanol®
01.03.05 Formulary Cancer Drugs Fund Omeprazole Dispersible tablets 
08.01.05 Formulary Cancer Drugs Fund Osimertinib 
07.04.02 Formulary Cancer Drugs Fund Oxybutynin 
08.01.05 Restricted Use Cancer Drugs Fund Paclitaxel albumin-bound Abraxane®
08.01.05 Formulary Cancer Drugs Fund Palbociclib Ibrance®
08.01.05 Formulary Cancer Drugs Fund Panobinostat Farydak®
08.01.05 Formulary Cancer Drugs Fund Pegaspargase Oncaspar®
08.01.05 Formulary Cancer Drugs Fund Pembrolizumab Keytruda®
08.01.05 Formulary Cancer Drugs Fund Pertuzumab Perjeta®
08.01.05 Formulary Cancer Drugs Fund Ponatinib Iclusig®
16.01 Formulary Cancer Drugs Fund Radium-223 Xofigo®
16.01 Formulary Cancer Drugs Fund Radium-223 Xofigosup>®
16.06 Formulary Cancer Drugs Fund Radium-223 Xofigo®
11.08.02 Restricted Use Cancer Drugs Fund Ranibizumab Lucentis®
01.03.01 Formulary Cancer Drugs Fund Ranitidine 
08.01.05 Formulary Cancer Drugs Fund Regorafenib Stivarga®
08.01.05 Formulary Cancer Drugs Fund Ribociclib Kisqali®
10.01.03 Restricted Use Cancer Drugs Fund Rituximab (rheumatology) MabThera®
13.05.03 Formulary Cancer Drugs Fund Secukinumab Cosentyx®
08.01.05 Formulary Cancer Drugs Fund Talimogene Iaherparepvec Imlygic®
06.06 Formulary Cancer Drugs Fund Teriparatide 
10.01.03 Restricted Use Cancer Drugs Fund Tocilizumab RoActemra®
07.04.02 Formulary Cancer Drugs Fund Tolterodine 
04.07.02 Formulary Cancer Drugs Fund Tramadol 
01.05 Restricted Use Cancer Drugs Fund Ustekinumab Stelara®
13.05.03 Formulary Cancer Drugs Fund Ustekinumab 
01.05.03 Restricted Use Cancer Drugs Fund Vedolizumab Entyvio®
08.01.05 Formulary Cancer Drugs Fund Vemurafenib Zelboraf®
08.01.05 Formulary Cancer Drugs Fund Venetoclax Venclyxto®
NHS NEL